CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Beijing Wantai Biolog Pha Ent Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Beijing Wantai Biolog Pha Ent Co Ltd
No.31 Science Park Road
Changping District
Phone: +86 1059528820p:+86 1059528820 BEIJING, BEJ  102206  China Ticker: 603392603392
Business Summary
Beijing Wantai Biological Pharmacy Enterprise Co Ltd is a China-based company mainly engaged in the production and sale of vaccine products. The Company operates two segments. Diagnostic segment produces and sells in vitro diagnostic reagents and instruments suitable for in vitro diagnostic reagent testing. Vaccine segment produces and sells vaccines. The in vitro diagnostic reagents mainly include enzyme-linked immunosorbent assay reagents, colloidal gold diagnostic reagents, biochemical diagnostic reagents, chemiluminescent diagnostic reagents, and others. The in vitro diagnostic instruments include fully automatic chemiluminescent immunoassay analyzers, dry fluorescent immunoassay analyzers, fully automatic nucleic acid purification, and others. The vaccines mainly include hepatitis E vaccine, bivalent human papillomavirus (HPV) vaccine and nasal spray COVID-19 vaccine.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023Yes----

Industries
SIC Code Description
2836 Biological products, except diagnostic substances
2835 In vitro and in vivo diagnostic substances
2833 Medicinal chemicals and botanical products
3845 Electromedical and electrotherapeutic apparatus

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board ZixinQiu 61 1/15/2024 1/13/2021
Chief Financial Officer YunLu 35 4/19/2024 4/19/2024
General Manager, Director ZhimingJiang 51 4/19/2024 1/15/2024
8 additional Officers and Directors records available in full report.

General Information
Number of Employees: 3,843 (As of 12/31/2023)
Outstanding Shares: 1,265,122,774 (As of 9/30/2024)
Shareholders: 50,137
Stock Exchange: SHA
Fax Number: +86 1089705849


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, January 28, 2025